MORGAN STANLEY PLC/CALL/SANOFI/132/0.1/20.09.24 Share Price

Warrant

DE000ME2AWX1

Market Closed - Börse Stuttgart 09:42:56 14/06/2024 pm IST
0.006 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/SANOFI/132/0.1/20.09.24
3 months-85.00%
6 months-88.46%
Date Price Change
14/24/14 0.006 0.00%
13/24/13 0.006 0.00%
12/24/12 0.006 +20.00%
11/24/11 0.005 -16.67%
10/24/10 0.006 0.00%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 09:42 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying SANOFI
Issuer Morgan Stanley
WKN ME2AWX
ISINDE000ME2AWX1
Date issued 20/10/2023
Strike 132
Maturity 20/09/2024 (97 Days)
Parity 10 : 1
Emission price 0.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.123
Lowest since issue 0.005
Spread 0.035
Spread %87.50%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
86.43 EUR
Average target price
108.2 EUR
Spread / Average Target
+25.18%
Consensus